Doctor profile · Federal record

Dr. Shervin Yousefian, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Mountain View, CA

  • NPI 1801055900
  • Accepts Medicare
  • MIPS 74.2 / 100 · 2023
  • 24 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2204 Grant RD Ste 103
Mountain View, CA 940403877
(650) 967-8841
fax (650) 967-8812

Credentials & registration

NPPES · NUCC
NPI registered
June 2008 — 18 yrs on file
Profile last updated
February 10, 2025
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
California #A125229

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1801055900. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,321
Distinct HCPCS
10
Medicare allowed
$84,212
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 900 14 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 107 70 $155
99215 Established patient office or other outpatient visit, 40-54 minutes 73 58 $215
99213 Established patient office or other outpatient visit, 20-29 minutes 63 49 $107
99205 New patient office or other outpatient visit, 60-74 minutes 49 49 $265
99214 Established patient office or other outpatient visit, 30-39 minutes 35 35 $113
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 34 16 $40
76536 Ultrasound scan of head and neck soft tissue 28 28 $153
96372 Injection of drug or substance under skin or into muscle 16 15 $17
99213 Established patient office or other outpatient visit, 20-29 minutes 16 16 $76

In context: peer comparison

Among 4 peers in Mountain View Endocrinology, Diabetes & Metabolism Physician, average services per provider: 213. This provider delivers 6.2× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,399
Transactions
88
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 22 $543.16
Lilly USA, LLC 17 $466.40
Beta Bionics, INC. 4 $237.05
Boehringer Ingelheim Pharmaceuticals, INC. 8 $191.71
Novo Nordisk INC 9 $184.79
Radius Health, INC. 5 $112.42
Dexcom, INC. 3 $81.83
Bayer Healthcare Pharmaceuticals INC. 3 $73.16
Sanofi-Aventis U.S. LLC 3 $72.62
Mannkind Corporation 3 $72.49
Ascensia Diabetes Care US INC. 3 $56.94
Alexion Pharmaceuticals, INC. 2 $56.77
Xeris Pharmaceuticals, INC. 3 $56.07
Kyowa Kirin, INC. 2 $50.41
Neurocrine Biosciences, INC. 1 $30.02

By nature of payment

Food and Beverage
$2,399

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
462
Patients
170
Total drug cost
$242,783
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 104 48 $1,922
Alendronate Sodium Generic 52 28 $868
Methimazole Generic 38 22 $468
Metformin Hcl Generic 36 18 $561
Prolia (Denosumab) Brand 29 28 $45,296
Jardiance (Empagliflozin) Brand 28 14 $43,446
Tymlos (Abaloparatide) Brand 25 0 $64,764
Trulicity (Dulaglutide) Brand 23 0 $46,693
Atorvastatin Calcium Generic 22 0 $550
Metformin Hcl ER (Metformin Hcl) Brand 22 12 $362

Frequently asked questions

Auto-generated from federal data
What is Dr. Shervin Yousefian's medical specialty?
Dr. Shervin Yousefian practices Endocrinology, Diabetes & Metabolism Physician in Mountain View, CA.
Where does Dr. Shervin Yousefian practice?
Dr. Shervin Yousefian practices at 2204 Grant RD Ste 103, Mountain View, CA 940403877. Office phone: 6509678841.
What is Dr. Shervin Yousefian's NPI?
Dr. Shervin Yousefian's National Provider Identifier (NPI) is 1801055900, issued by NPPES.
Does Dr. Shervin Yousefian accept Medicare assignment?
Yes. Dr. Shervin Yousefian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shervin Yousefian commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.